Showing results (61-70 of 102) with videos related to
Sort By:
Pageof 11
Journal of Affective Disorders|November 8, 2024
A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disordersHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.Journal of Affective Disorders|July 17, 2024
Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic reviewSabrina Wong, Gia Han Le, Shreya Vasudeva, et al.Expert Opinion on Pharmacotherapy|March 22, 2024
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic reviewAlexia Leber, Ranuk Ramachandra, Felicia Ceban, et al.Acta Neuropsychiatrica|February 13, 2026
The Effect of GLP-1 Receptor Agonists on Autophagy: Insights Gathered from Research Evaluating Neurodegenerative Disorders With These AgentsMaria-Christina Sioufi, Isabela Heroiu, Sabrina Wong, et al.Journal of Affective Disorders|September 20, 2024
Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysisGia Han Le, Sabrina Wong, Hezekiah Au, et al.Journal of Medical Internet Research|February 19, 2025
Cost Utility Analysis of Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder: Randomized Controlled TrialWenjing Zhou, Yan Chen, Herui Wu, et al.Journal of Psychiatric Research|March 7, 2024
Associations between somatic symptoms and remission of major depressive disorder: A longitudinal study in ChinaYingchen Jiang, Dongjian Zhu, Xinyu Huang, et al.Expert Opinion on Investigational Drugs|April 25, 2023
Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trialsGia Han Le, Emily S Gillissie, Taeho Greg Rhee, et al.Acta Neuropsychiatrica|February 14, 2025
Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic reviewHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.Psychoneuroendocrinology|April 3, 2026
The effect of GLP-1 receptor agonists on anxiety: A systematic reviewYu Tian Yi, Yang Jing Zheng, Stavroula I Bargiota, et al.Pageof 11